» Articles » PMID: 17978284

Confirmation Study of Prostate Cancer Risk Variants at 8q24 in African Americans Identifies a Novel Risk Locus

Overview
Journal Genome Res
Specialty Genetics
Date 2007 Nov 6
PMID 17978284
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate cancer is a common complex disease that disproportionately affects men of African descent. Recently, several different common variants on chromosome 8q24 have been shown to be associated with prostate cancer in multiple studies and ethnic groups. The objective of this study was to confirm the association of 8q24 markers with prostate cancer in African Americans. We genotyped 24 markers along 8q24 and 80 unlinked ancestry informative markers in a hospital-based case-control sample of 1057 African American men (490 prostate cancer cases and 567 controls). Association analyses of 8q24 markers with prostate cancer risk were adjusted for both global and local 8q24 admixture stratification using estimates from ancestry informative markers. We report that rs7008482, which maps to the 8q24.13 region, is an additional independent prostate cancer risk variant (P = 5 x 10(-4)), and we also replicate the association of rs16901979 with prostate cancer (P = 0.002). Other published risk variants in the region such as rs1447295 and rs6983267 showed a similar direction and magnitude of effect, but were not significant in our population. Both rs7008482 and rs16901979 independently predicted risk and remained significant (P < 0.001) after controlling for each other. Our data combined with additional replications of 8q24 markers provide compelling support for multiple regions of risk for prostate cancer on 8q24.

Citing Articles

Single nucleotide polymorphism within chromosome 8q24 is associated with prostate cancer development in Saudi Arabia.

Osman A, Alharbi S, Ahmed A, Elbagir A Asian J Urol. 2024; 11(1):26-32.

PMID: 38312824 PMC: 10837665. DOI: 10.1016/j.ajur.2022.03.012.


Genetic and biological drivers of prostate cancer disparities in Black men.

Gong J, Kim D, Freeman M, Kim H, Ellis L, Smith B Nat Rev Urol. 2023; 21(5):274-289.

PMID: 37964070 DOI: 10.1038/s41585-023-00828-w.


Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent.

Johnson J, Woods-Burnham L, Hooker Jr S, Batai K, Kittles R Front Oncol. 2021; 11:770500.

PMID: 34820334 PMC: 8606679. DOI: 10.3389/fonc.2021.770500.


Immune Inflammation Pathways as Therapeutic Targets to Reduce Lethal Prostate Cancer in African American Men.

Kiely M, Ambs S Cancers (Basel). 2021; 13(12).

PMID: 34207505 PMC: 8227648. DOI: 10.3390/cancers13122874.


Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.

Dovey Z, Nair S, Chakravarty D, Tewari A Cancer Rep (Hoboken). 2021; 4(5):e1340.

PMID: 33599076 PMC: 8551995. DOI: 10.1002/cnr2.1340.


References
1.
Severi G, Hayes V, Padilla E, English D, Southey M, Sutherland R . The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007; 16(3):610-2. DOI: 10.1158/1055-9965.EPI-06-0872. View

2.
Liu W, Chang B, Sauvageot J, Dimitrov L, Gielzak M, Li T . Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array. Genes Chromosomes Cancer. 2006; 45(11):1018-32. DOI: 10.1002/gcc.20369. View

3.
Haiman C, Patterson N, Freedman M, Myers S, Pike M, Waliszewska A . Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet. 2007; 39(5):638-44. PMC: 2638766. DOI: 10.1038/ng2015. View

4.
Schumacher F, Feigelson H, Cox D, Haiman C, Albanes D, Buring J . A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 2007; 67(7):2951-6. DOI: 10.1158/0008-5472.CAN-06-3591. View

5.
Tan J, Chow V . Cellular expression, localization and interactions of the product of the human MOST-1 gene associated with breast and prostate cancers. Int J Oncol. 2006; 30(1):81-9. View